Breakthrough for MRSA vaccination

A vaccine that contains four staphylococcus bacteria proteins can effectively protect against MRSA infection, a US study in mice has found.

The researchers showed that the vaccine, developed using a novel technique known as reverse vaccinology, was effective at preventing a number of strains of the infection.

Previous attempts to develop an MRSA vaccine using killed or live attenuated bacteria have only provided partial immunity.

The researchers tried to create a vaccine that would provide much broader protection against MRSA by recognising the specific cell-surface proteins responsible for the virulence of the bacteria.

Eight staphylococcal genome sequences were analysed, leading to the identification of 19 surface proteins that are present in all known strains of MRSA.

The researchers then vaccinated mice with each protein to see which would give immunity to Staphylococcus aureus infection.

Four proteins provided significant reduction in bacterial load. These were then used to create a single vaccine, which was given to mice that were subsequently infected with one of five MRSA strains.

Mice given the vaccine had a significantly improved survival rate for all strains. Against two of the strains, the vaccine produced 100 per cent survival, compared with 20 and 40 per cent survival in unvaccinated mice.

Dr Olaf Schneewind, professor of microbiology at the University of Chicago and director of the study, described this as an important breakthrough.

‘This organism has learned how to evade nearly all of our current antibiotics. So, generating protective immunity against invasive MRSA has become an important goal,’ he said.

PNAS 2006; 103: 16,942–7

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register

Already registered?

Sign in

Follow Us:

Just published

Health secretary has 'overplayed his hand' on remote consultation benefits, RCGP chair warns

Health secretary has 'overplayed his hand' on remote consultation benefits, RCGP chair warns

Health secretary Matt Hancock has ‘overplayed his hand’ by pushing for total use...

GMC defers revalidation for a further 9,000 doctors due to pandemic

GMC defers revalidation for a further 9,000 doctors due to pandemic

Around 9,000 doctors who are due to revalidate between March and July 2021 will have...

NHS England praises GPs after steep rise in general practice appointments

NHS England praises GPs after steep rise in general practice appointments

NHS England primary care medical director Dr Nikki Kanani has thanked GPs and their...

Half of GPs say patients harmed by delays to care during COVID-19 pandemic

Half of GPs say patients harmed by delays to care during COVID-19 pandemic

Nearly half of GPs say patients on their list have come to harm because of delays...

Viewpoint: Test and trace isn't working - could GPs do it better?

Viewpoint: Test and trace isn't working - could GPs do it better?

The outsourced test and trace system isn't working, says Dr Simon Hodes. It's time...

Doctors call for test and trace millions to be diverted to primary care and local NHS

Doctors call for test and trace millions to be diverted to primary care and local NHS

Doctors have urged the government to divert hundreds of millions of pounds from the...